Published in N Engl J Med on September 25, 1969
Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery (1970) 2.38
Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med (1970) 2.33
Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes. J Clin Invest (1977) 2.07
Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis. Br Med J (1971) 1.95
Use of radioactive fibrinogen for detecting rejection of human renal transplants. Br Med J (1970) 1.65
A primate model of hyperacute renal allograft rejection. Am J Pathol (1975) 1.09
Hyperacute rejection of renal homografts: with particular reference to coaglation changes, humoral antibodies, and formed blood elements. Transplant Proc (1971) 1.08
The nature of experimental second-set kidney transplant rejection. 1. The role of coagulation in hyperacute (second-set) renal allotransplant rejection in dogs. Br J Exp Pathol (1970) 1.01
Procoagulant activity in gastroenterology. Gut (1990) 0.87
Hyperacute renal allograft rejection in the primate. Therapeutic limitations of antiplatelet agents alone and combined with heparin. Am J Pathol (1976) 0.86
Menstrual blood loss and fibrin degradation products. Br Med J (1972) 0.79
Functional aspects of the rejection of transplanted kidneys. Calif Med (1971) 0.78
The nature of experimental second-set kidney transplant rejection. 4. The disturbed haemodynamics and the general significance of failure to perfuse the outer cortical glomeruli in acute renal failure. Br J Exp Pathol (1971) 0.76
Extensive intraglomerular fibrin deposition after renal transplantation: recovery without anticoagulation. Can Med Assoc J (1975) 0.75
The role of hyperimmune alloantiserum in allograft survival. Immunology (1973) 0.75
Urinary excretion of factor VIII after renal transplantation. Br Med J (1979) 0.75
Alterations in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri. Infect Immun (1983) 6.43
Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34
Homotransplantation of the Canine Liver as an Orthotopic Vascularized Graft: Histologic and Functional Correlations During Residence in the New Host. Am J Pathol (1962) 3.14
Pathogenesis of salmonellosis. Studies of fluid secretion, mucosal invasion, and morphologic reaction in the rabbit ileum. J Clin Invest (1973) 2.78
Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med (1968) 2.70
Enteropathogenicity of Aeromonas hydrophila and Plesiomonas shigelloides: prevalence among individuals with and without diarrhea in Thailand. Infect Immun (1982) 2.50
Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med (1970) 2.43
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33
Effect of heparin on the activation of factor XII and the contact system in plasma. Thromb Haemost (1991) 2.29
Platelet function in hyperlipoproteinemia. N Engl J Med (1974) 2.23
Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammation. Dig Liver Dis (2005) 2.18
Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N Engl J Med (1983) 2.18
Orthotopic autotransplantation and allotransplantation of the liver: functional and structural patterns in the dog. Ann Surg (1967) 2.17
Intrarenal distribution of blood flow in the transplanted dog kidney: effect of denervation and rejection. J Clin Invest (1967) 2.14
Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg (1996) 2.11
Interaction of plasma kallikrein with the C1 inhibitor. J Immunol (1970) 2.07
Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med (1967) 2.06
Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc Natl Acad Sci U S A (1972) 2.01
The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J Exp Med (1973) 1.92
Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest (1975) 1.88
Disseminated intravascular coagulation (DIC): an approach. Am J Med (1972) 1.87
Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies. Gastroenterology (1975) 1.83
Subtotal parathyroidectomy in chronic renal failure: a seven-year experience in a dialysis and transplant program. Ann Surg (1971) 1.83
Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med (1975) 1.82
Urine fibrinogen fragments in human renal allografts. A possible mechanism of renal injury. N Engl J Med (1968) 1.80
Immunohistochemistry of glomerulonephritis using horseradish peroxidase and fluorescein-labeled antibody: a comparison of two technics. Am J Clin Pathol (1970) 1.79
Survival of patients undergoing chronic hemodialysis and renal transplantation. N Engl J Med (1973) 1.74
The rising incidence of clinical Babesia microti infection. Hum Pathol (1981) 1.71
Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology (1994) 1.70
Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci U S A (1976) 1.69
Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med (1992) 1.65
Human renal isografts: a clinical and pathologic analysis. Medicine (Baltimore) (1968) 1.63
Purification and characterization of a potent 70-kDa thiol lysyl-proteinase (Lys-gingivain) from Porphyromonas gingivalis that cleaves kininogens and fibrinogen. J Biol Chem (1993) 1.61
Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy. Medicine (Baltimore) (1969) 1.61
Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57
Pathophysiology of Salmonella diarrhea in the Rhesus monkey: Intestinal transport, morphological and bacteriological studies. Gastroenterology (1974) 1.56
Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest (1975) 1.55
Plasma kallikrein and Hageman factor in Gram-negative bacteremia. Ann Intern Med (1970) 1.53
Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins. J Clin Invest (1969) 1.52
Glomerulonephritis (third of three parts). N Engl J Med (1974) 1.52
Human renal allografts. The role of vascular injury in early graft failure. Medicine (Baltimore) (1971) 1.49
Renal outcome 25 years after donor nephrectomy. J Urol (2001) 1.47
Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest (1982) 1.45
Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med (1978) 1.45
The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states. Ann Intern Med (1969) 1.45
Activation of plasminogen by human plasma kallikrein. Biochem Biophys Res Commun (1969) 1.44
Senescence and the renal vasculature in normal man. Circ Res (1974) 1.43
Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest (1977) 1.42
Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters. Blood (1998) 1.42
Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation. Am J Med (1967) 1.42
Assessing glomerular filtration rate by estimation equations in kidney transplant recipients. Am J Transplant (2006) 1.41
Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen. Biochemistry (1981) 1.41
Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor. J Clin Invest (1984) 1.40
Invited letter concerning: aprotinin. J Thorac Cardiovasc Surg (1991) 1.40
Intravascular coagulation (IVC) in human renal allograft rejection. Transplant Proc (1969) 1.39
Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. Blood (1986) 1.38
The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J Clin Invest (1993) 1.38
Surface-mediated defense reactions. The plasma contact activation system. J Clin Invest (1984) 1.35
Recovery of Venezuelan equine encephalomyelitis virus in Panama. A fatal case in man. Am J Trop Med Hyg (1968) 1.35
Seasonal variation of transmission risk of Lyme disease and human babesiosis. Am J Epidemiol (1987) 1.35
Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases. J Clin Invest (1970) 1.35
Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein. J Clin Invest (1969) 1.34
Laparoscopic bilateral synchronous nephrectomy for autosomal dominant polycystic kidney disease: the initial experience. J Urol (2001) 1.34
More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-reduction filters. Transfusion (1996) 1.33
Simplified hippuran clearance. Measurement of renal function in man with simplified hippuran clearances. Nephron (1966) 1.33
Acute diffuse interstitial nephritis. Review of the literature and case report. Am J Med (1968) 1.32
Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest (1966) 1.30
Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine (Baltimore) (1968) 1.28
Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis (1985) 1.27
Perforation of the colon in renal homograft recipients. A report of 11 cases and a review of the literature. Ann Surg (1986) 1.26
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. Am J Med (1970) 1.26
Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochemistry (1984) 1.25
Heparin and aspirin in the treatment of hyperacute rejection of renal allografts in presensitized dogs. Transplantation (1970) 1.23
Origin of the high molecular weight activator of prekallikrein. J Biol Chem (1973) 1.22
Renal transplantation in the inbred rat. I. Morphologic, immunologic, and functional alterations during acute rejection. Transplantation (1967) 1.22
Sauna baths in the treatment of chronic renal failure. Trans Am Soc Artif Intern Organs (1966) 1.22
Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest (1983) 1.22
Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum (1977) 1.21
Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen. J Clin Invest (1982) 1.21
Formation of human plasma kinin. N Engl J Med (1974) 1.21
Editoral: Cardiovascular disease in dialysis patients. N Engl J Med (1974) 1.20
Uremic pericarditis. Clinical features and management. Circulation (1968) 1.20
Human renal allografts. Interpretation of morphologic and immunohistochemical observations. Am J Pathol (1968) 1.19
Human plasma prekallikrein: a rapid high-yield method for purification. Eur J Biochem (1979) 1.17
An immunosupressive site of action of heterologous antilymphocyte serum. Lancet (1967) 1.17
The regulation of human factor XIIa by plasma proteinase inhibitors. J Biol Chem (1985) 1.17
Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb (1992) 1.16
Fluid and electrolyte transport in rhesus monkeys challenged intracecally with Shigella flexneri 2a. Infect Immun (1976) 1.16
Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Invest (1975) 1.16
Liver disease in kidney transplant patients receiving azathioprine. Arch Intern Med (1973) 1.15